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Abstract
Background: The Warburg effect has been found in a wide spectrum of human cancers, however
the underlying mechanisms are still unclear. This study aims to explore the role of cellular oxidative
stress in relation to glycolysis and the Warburg effect in hepatoma cells.
Methods: Various cell lines combining environmental hypoxia was used as an in vitro model to
mimic tumor microenvironment in vivo. Superoxide dismutases (SOD) and xanthine oxidase (XO)
gene transfection were used to produce various cellular redox levels. 2',7'-dichlorofluorescin
(DCF) fluorescence and ESR spectrum were used to detect cellular reactive oxygen species (ROS).
Results: We found that endogenous or exogenous interference with the cellular oxidative stress
can sensitively regulate glycolysis and the Warburg effect in hepatoma cells. Hepatoma cells
displayed a high level of free radicals compared to immortalized normal hepatocyte cells. Increasing
the level of ROS stress in hepatoma cells can directly upregulate HIF-1 and activate glycolysis
without requirement of a hypoxic condition. This explains the mechanism whereby aerobic
glycolysis, i.e. the Warburg effect arises. Either endogenously upregulating SOD or exogenously
administration with antioxidant can, through downregulating ROS level, effectively regulate energy
pathways in hepatoma cells and can inhibit the growth of tumor cells and xenograft tumors.
Conclusion: This study suggests that the Warburg effect was related to an inherently high level
of cellular ROS and HIF-1. Hepatoma cells adaptation to hypoxia for survival and rapid growth
exploits oxidative stress ectopically activated glycolysis to compensate the energy supply. This
specific mechanism in which tumor cells through cellular oxidative stress activate glycolysis to meet
their energy metabolism requirement could be exploited to selectively kill tumor cells.
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In the presence of oxygen, normal cells completely oxidize
glucose to CO2 and H2O, and generate ATP through aero-
bic oxidation. However, over 70 years ago, Warburg
observed that cancer cells exhibit enhanced conversion of
glucose to lactate (aerobic glycolysis) and depend heavily
on the glycolytic pathway to meet their energy needs even
in the presence of an adequate oxygen supply [1]. During
the past decades, the Warburg effect has been found in a
wide spectrum of human cancers, however the underlying
mechanisms are still unclear.
Hypoxia in the tumor microenvironment is a common
feature of solid tumors. Rapid growth of cancer cells and
rapid expansion of the tumor mass usually leaves the gen-
eration of new vasculature lagging behind. The lack of
oxygen delivery results in local ischemia and hypoxia of
the tumor [2]. Such a hypoxic environment inside the
tumor limits the availability of oxygen for use in mito-
chondrial respiration and production of ATP, and forces
tumor cells to up-regulate the glycolytic pathway, in
which oxygen is not required, as a main source of energy
to maintain a sufficient energy supply for tumor growth
[3,4].
Hypoxia is known to stimulate mitochondria to release
ROS (mROS). Under hypoxic conditions, mitochondria
participate in a ROS burst generated at complex III of the
electron transport chain [5]. ROS is an important second-
ary messenger in signaling transduction [6,7]. The
increased ROS in response to hypoxia can promote cancer
cell survival and tumor growth through activating hypoxia
inducible factor 1α (HIF-1α) [8].
Under normal conditions, intracellular ROS are main-
tained at a low level by various enzyme systems which
maintain the in vivo redox homeostasis. Tumor cells usu-
ally have an unbalanced redox status, oxidative levels in
tumor cells being relatively higher [9-11]. Moreover, mod-
erately enhanced oxidative stress by slight upregulation of
the ROS level can promote cancer cell growth but has no
effect on normal cells [7,12]. This suggests that cancer
cells are able to adapt to oxidative stress and that the sur-
vival microenvironment required for cancer cells and nor-
mal cells is different.
Given that tumor cells display the Warburg effect and that
their survival relies on glycolysis to supply energy, it is of
interest to study the role of oxidative stress in relation to
the Warburg effect. Our previous study has already shown
that hepatoma cells growth was dependent on cellular
ROS level [13]. We have found that ROS could, through
HIF-1, regulate gene expression involved in glycolysis in
response to hypoxia [14]. Another recent study has also
shown that the antitumorigenic effect of antioxidants is
HIF-dependent [15]. These results suggest that ROS could
through HIF-1 regulate glycolysis. However, why tumor
cells rely on glycolysis in the presence of oxygen, i.e. the
Warburg effect, and whether the cellular ROS are involved
in regulation of the Warburg effect remains to be defined.
Prior studies have shown that the cellular redox microen-
vironment can be altered through transfection by MnSOD
genes [16]. In the present study, we tested the effects of
different cellular status on the Warburg effect. High oxida-
tive level was achieved by either exposure to hypoxia or
overexpression of xanthine oxidase, and a decreased oxi-
dative level was achieved by antioxidant treatment or
overexpression of MnSOD. For the first time, we found
that manipulating cellular oxidative stress microenviron-
ment in hepatoma cells can regulate the Warburg effect.
Results
Cancer cells under hypoxic stress exhibit a survival 
advantage paralleled by compensatory upregulated 
glycolysis
We first examined the effects of hypoxia on hepatoma
cells and immortalized normal liver cells. L02 and Chang
liver cells are immortalized non-tumor cell line derived
from normal liver tissue and are considered an in vitro
model of nonmalignant liver [17-20]. We compared the
differential susceptibility of human hepatoma cell lines
SMMC-7721 and HepG2, and human normal liver cell
lines L02 and Chang subject to 2% O2 severe hypoxic con-
dition. The survival of human hepatoma cells and hepato-
cyte cells in response to hypoxia were both inhibited in a
time-dependent fashion that decreased with the hypoxia
time (Fig. 1a). The survival rate of hepatoma cells was sig-
nificant higher than hepatocyte cells during 24 h hypoxia.
This finding suggests that hepatoma cells have a higher
tolerance to hypoxia than hepatocyte cells. The decreased
survival ratio induced by hypoxia in hepatoma cells and
hepatocyte cells was attenuated by pre-treatment with 5
mM glucose in both cases (Fig. 1b). Both SMMC-7721
and HepG2 cells appear more sensitive to glucose treat-
ment than hepatocyte cells. This suggests hepatoma cells
rely more heavily on glycolysis. In order to verify that
hepatoma cells 7721 and HepG2 have a higher glycolytic
ability, we further examined the activity of lactate dehy-
drogenase (LDH), a key enzyme involved in glycolysis,
and lactate synthesis and glucose uptake in cells. As illus-
trated in Fig. 1c, cells under hypoxic condition produced
a significantly greater level of LDH activity, lactate produc-
tion and glucose consumption than under normoxia.
Hepatoma cell lines produced about 20-fold LDH activity
and hepatocyte cell lines produced about 10-fold LDH
activity. LDH activity appears to be the most sensitive
parameter reflecting glycolytic activity. The increased gly-
colytic activity induced by hypoxia was also shown to be
clearly greater in hepatoma cells than that in hepatocyte
cells. This also suggests that hepatoma cells benefit fromPage 2 of 15
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to hepatocyte cells.
The involvement of ROS in regulating glycolysis under 
hypoxia
It is known that hypoxia can stimulate ROS generation.
We examined the ROS level in SMMC-7721 cells sub-
jected to 0.5%, 2%, 5% O2 of hypoxia. The levels of ROS
monitored using DCF fluorescence (DCFH oxidation)
increased with the degree of hypoxia (Fig. 2a). Meanwhile
cells showed no change in fluorescence when labeled with
the oxidation insensitive probe. The increased ROS was
paralleled by upregulated LDH activity (Fig. 2b). α-lipoic
acid (α-LA) is a powerful antioxidant, it can scavenge var-
ious ROS [21]. Pre-treatment of cells with 5 mM α-LA
prior to hypoxia resulted in a decrease in LDH activity
(Fig. 2c). This suggests that in hepatoma cells ROS is
involved in up-regulating glycolysis under hypoxic condi-
tions.
Studies to identify the intracellular oxygen sensor suggest
that HIF1-α is a central regulator of the response to
hypoxia [22]. Hypoxia induced ROS has been reported to
be able to stabilize HIF1-α [5]. Western blot analyses of
nuclear extracts revealed that levels of HIF1-α protein
were enhanced by the degree of hypoxia (Fig. 2d). The
HIF1-α activation was paralleled by ROS generation (Fig.
2a). Hypoxia-induced HIF1-α was suppressed by preincu-
bation with 5 mM α-LA (Fig. 2d). These findings suggest
the involvement of ROS generation in HIF1-α stabiliza-
tion by hypoxia, and indicate that hypoxia induced ROS
could regulate glycolytic gene expression by activating
HIF1-α.
Enhanced endogenous ROS caused an increase in 
glycolytic activity
If hypoxia induced HIF1-α and glycolytic enzyme gene
expression is ROS-dependent, ROS should activate gene
expression by activating HIF1-α expression in normoxia.
To test this hypothesis, an XO-transfected SMMC-7721
hepatoma cell line which has elevated ROS was used to
assess the effects of endogenous ROS on HIF1-α expres-
sion. As illustrated in Fig 3a, the pLNCX2-XO-7721 cell
line has elevated ROS levels, as indicated by DCF fluores-
cence. The Western blot showed that XO-transfected 7721
cells (XO+) have increased XO and HIF1-α expression (Fig
3b). Antioxidant α-LA treatment reduced ROS (Fig. 3a),
and also attenuated HIF1-α expression (Fig. 3b). This
result confirms that HIF1-α can be activated in a ROS-
dependent manner. We next tested if ROS regulates
expression of hypoxia-induced genes required in glycoly-
sis. Hexokinase (HK) is a key enzyme involved in glycoly-
sis. We analyzed HK2 protein expression and LDH activity
in XO-transfected 7721 cells. The results show that XO-
transfected 7721 cells have increased HK2 protein level
and LDH activity compared to control 7721 cells (Fig. 3b
and 3c). This suggests that ROS can also stimulate glyco-
lytic activity independent of hypoxia and that aerobic gly-
colysis in tumor cells is related to the inherently high level
of ROS in tumor cells.
Reduction of cellular ROS level inhibits glycolytic activity
The above observations show that increased ROS benefits
cancer cells through up-regulation of glycolysis. We fur-
ther tested whether the ROS induced oxidative cellular sta-
tus is critical for the Warburg effect. To test this possibility,
we used the antioxidant α-LA to reduce the cellular oxida-
tive status and examined the glycolytic activity of cells. As
shown in Fig. 4a and 4b, incubation of SMMC-7721 cells
with 5 mM α-LA caused a decrease of ROS and down-reg-
ulation of LDH activity, suggesting the reliance of glyco-
lytic activity on ROS.
In order to confirm the dependence of glycolysis activa-
tion on cellular oxidative stress status, we further estab-
lished a sense MnSOD transfected cell line, which has an
endogenous low level of ROS (Fig. 4a). Consistent with
the exogenous antioxidant treatment, the sense MnSOD
transfected cells have a low level of LDH activity (Fig. 4b).
These findings suggest that the specific higher level of oxi-
dative states within cancer cells is important for the War-
burg effect.
Comparison of hepatoma and hepatocyte cells in response to hypoxiaFigure 1 (see previous page)
Comparison of hepatoma and hepatocyte cells in response to hypoxia. (a) Survival ratio of hepatoma and hepato-
cytes cells in response to hypoxia. Hepatoma cell lines SMMC7721 and HepG2, and hepatocyte cell lines L02 and Chang were 
cultured under 2% O2 hypoxic condition for indicated times, and viable cells were assessed by live cell counting using trypan 
blue exclusion method. Data were expressed as relative to control values at normaxia incubated for the same period. (b) Glu-
cose increases cell survival in response to hypoxia. Cells were pretreated with 5 mmol glucose and cultured under 2% O2 
hypoxic condition for 24 h. (c) Glycolytic activity changes in response to hypoxia. Cells were cultured for 24 h under 2% O2. 
LDH activity, cellular lactate synthesis and glucose uptake were measured as described in materials and methods. LDH activity 
levels, cellular lactate production and glucose consumption are expressed relative to control values at normoxia. Control value 
is presented as 1. *, P < 0.05, difference between hepatoma cells and hepatocyte cells (a, c); **, P < 0.05, versus cells in the 
absence of glucose treatment (b). Results are means ± S.D. of four independent experiments.Page 4 of 15
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activity in hepatoma cells and immortalized normal liver 
cells
These findings suggest that a higher cellular oxidative
stress level favored activation of glycolysis in cancer cells.
ROS usually have a very short half-life, and can be rapidly
degraded. In order to validate ROS detection using DCF
and understand the difference in ROS levels and types in
various cell lines, cellular ROS were further examined by
the ESR method using BMPO spin trap. As shown in Fig.
5a, 7721 hepatoma cells produced a robust BMPO-OH
signal (Fig. 5a.a), however this BMPO-OH signal was
undetectable in the immortalized normal L02 liver cells
(Fig. 5a.b). In SOD-7721 cells this free radical signal was
attenuated (Fig. 5a.c), and in SOD-AS7721 cells this free
radical signal was enhanced (Fig. 5a.d). The BMPO-OH
adduct signal was completely quenched by pre-adminis-
tration of cells with 100 U/mL of SOD, a specific superox-
ide anion scavenger (Fig. 5a.e). This suggests that the main
source of free radicals captured in SMMC-7721 hepatoma
cells was superoxide anion free radical. The ESR experi-
ment further confirmed that hepatoma cells were under a
relatively higher level of ROS stress.
Meanwhile, the measurement of relative LDL activity
showed that cellular glycolytic activity is related to the
ROS stress level. Paralleled with the change of ROS level
(Fig. 5a), LDH activities in each cell lines displayed in dif-
ferent levels (Fig. 5b). SOD-AS7721 which has the highest
ROS level, accordingly displayed the highest LDH activity.
However, SOD-7721 and L02 cells which have relative
lower levels of ROS, exhibited significantly lower levels of
LDH activity compared to SMMC-7721 cells. This con-
firms that ROS can regulate glycolytic activity independ-
ently of hypoxia.
Decreasing cellular oxidative stress inhibits tumor growth 
in vitro and in vivo
We further tested whether the change of cellular oxidative
states could influence tumor growth. Either antioxidant α-
LA treatment or MnSOD transfection were used to scav-
enge cellular ROS and decrease the cellular oxidative stress
level. As shown in Fig. 6a, antioxidant interference and
SOD transfection both significantly inhibit hepatoma
cells growth. Combining the results from Fig. 4, these
results suggest that decreasing cellular oxidative stress
could through inhibiting glycolytic activity in tumor cells
inhibit tumor cells growth. Moreover, α-LA was shown to
inhibit SMMC7721 hepatoma cells growth in a dose-
dependent manner (Fig. 6b), and in a certain dose (2.5
mM and 5 mM) α-LA induced hepatoma cell apoptosis
(Fig. 6c). However, the same concentration of α-LA has no
obvious effect on immortalized normal L02 liver cells.
This suggests that oxidative stress in hepatoma cells can be
exploited to selectively kill cancer cells.
In keeping with the results of the in vitro experiments,
nude mice injected with SMMC-7721 hepatoma cells
formed bigger xenograft tumors than those injected with
SOD-7721 cells. As shown in Fig. 6d, mice injected with
SMMC-7721 cells start to form visible tumor by 5 days
(about 1 mm) with subsequent rapid growth. Mice
injected with SOD-7721 cells start to form tumor at about
10–15 days, and the tumors grow slowly. Apart from
SOD-cells resulting in a delay in tumor formation in nude
mice, it also gives rise to significantly smaller tumors than
SMMC-7721 cells as judged by total tumor mass (Fig. 6e).
These results from xenograft tumors confirm that reduc-
tion of oxidative level in tumor cells could inhibit tumor
growth.
Discussion
The Warburg effect is the basis for the widespread applica-
tion of positron emission tomography, established in the
mid 1990s, in which a glucose analog tracer is used to dif-
ferentiate normal and tumor tissue, as tumor tissue takes
up glucose more avidly [23]. The Warburg effect has been
observed in various tumor cells, including solid tumors
and leukemia, and is recognized to represent a prominent
metabolic characteristic of malignant cells [24]. At present
several possible mechanisms have been proposed to
explain this metabolic difference of tumor cells. These
ROS up-regulate glycolysis in hepatoma cells under hypoxiaFigure 2 (see previous page)
ROS up-regulate glycolysis in hepatoma cells under hypoxia. (a) Hypoxia stimulates ROS generation. SMMC-7721 
hepatoma cells were exposed to 0.5% O2, 2% O2, and 5%O2 for 24 h, and ROS generation was determined by DCF fluores-
cence using flow cytometry. (b) LDH activity increases in response to hypoxia. SMMC-7721 hepatoma cells were incubated for 
24 h under indicated hypoxic conditions, and LDH activity was measured as described in "Materials and methods". (c) The 
effect of antioxidant α-LA on LDH activity under hypoxia. Cells were pre-treated with or without 5 mmol/L α-LA and expo-
sure to 2% O2 for 24 h. Scavenging ROS by α-LA attenuates hypoxia-induced LDH activity. (d) ROS is involved in hypoxia-
induced HIF-1α stabilization. Cells were subjected to different hypoxic condition for 24 h, in some cases cells were pre-treated 
with 5 mM α-LA. Nuclear HIF-1α levels were assessed by Western blot as described in Materials and methods. β-actin shows 
the internal reference for semiquantitative loading in each lane. The present blots are representative of three experiments. 
Columns, data were normalized to 21% O2 normoxia controls (a, b, c) and represent the means ± S.D. of four independent 
experiments. *, P < 0.05 versus normoxia. **, P < 0.05 versus cells in the absence of α-LA treatment under 2% O2 hypoxia.Page 6 of 15
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oncogenic transformation [27,28], and tumor microenvi-
ronment [29]. However, the exact mechanisms causing
tumor cells to use this primitive and less energy-efficient
pathway to generate ATP to maintain rapid growth are still
to be explained.
It is known that hypoxia is one of the distinguishing and
near-universal hallmarks of cancer growth. The cellular
environmental hypoxic conditions could force cancer
cells to use glycolysis to generate ATP to meet their energy
requirement. Environmental hypoxia has been used as an
in vitro model to study the Warburg effect in vivo [30,31].
We exposed cultured hepatoma cells to environmental
hypoxia and analyzed changes in glycolytic activity in
response to hypoxia. We compared the effect of hypoxia
on hepatoma cells and immortalized normal liver cells.
L02 and Chang liver cell lines were used as the nontrans-
formed normal cells to compare their biological features
with the control malignant cells [18-20]. Our results show
that hepatoma cells have a higher tolerance to hypoxia
than liver cells and that hepatoma cells under hypoxic
stress exhibit a survival advantage compared to liver cells
(Fig. 1). Pretreatment with glucose before hypoxia signifi-
cantly increased the survival of heaptoma cells. These
results indicate that cancer cells rely more heavily on gly-
colysis than normal cells. The ability of hepatoma cells to
upregulate glycolysis in response to hypoxia was further
confirmed by the finding of increased lactate synthesis
and glucose consumption, and enhanced activity of LDH,
a key enzyme in glycolysis. It is known that normal cells
mainly rely on aerobic oxidation to meet the energy
requirement for growth. Under hypoxia conditions glyco-
lysis can be correspondingly upregulated in normal cells
via the Pasteur effect. However, in response to prolonged
hypoxia (24 h-hypoxia) (Fig. 1a), as the excess hypoxia
has impeded aerobic oxidation, upregulated glycolysis is
insufficient to compensate the energy deficit, which will
lead to damage of normal cells and induce apoptosis. In
the case of cancer cells under the same hypoxic conditions
their upregulated glycolytic activity can be further acti-
vated extending a survival advantage to tumor cells in
response to hypoxia compared to normal cell lines.
We further addressed the relationship between upregu-
lated gylcolysis and ROS in response to hypoxia in
hepatoma cells. It is known that hypoxia can stimulate
ROS generation. Although the stimulation of ROS during
hypoxia has been already described, how ROS relate to
glycolysis in cancer cells under hypoxia is not clear. Our
studies show that the dependency on glycolysis in
hepatoma cells was actually related to ROS (Fig. 2). ROS
were increased with the degree of hypoxia (Fig 2a). The
increased ROS were associated with upregulated glycolytic
activity (Fig 2b). A decline of ROS caused by antioxidant
pre-treatment before hypoxia in hepatoma cells resulted
in a decrease of LDH activity (Fig. 2c). These results sug-
gest that ROS are involved in upregulating glycolytic activ-
ity in hypoxic hepatoma cells.
In order to understand the mechanism whereby ROS
upregulates glycolysis under hypoxia, we investigated the
role of ROS in regulation of HIF1-α. Hypoxia is known to
be capable of activating HIF1-α. HIF1-α is a key transcrip-
tion factor which can up-regulate a series of genes
involved in glucose transport, glycolysis, erythropoiesis,
angiogenesis, vasodilation, and respiratory rate [32,33].
We observed that hypoxia increased the both of ROS level
and HIF1-α activity. When ROS level was reduced by anti-
oxidant α-LA pre-treatment, hypoxia induced HIF1-α
expression was downregulated (Fig. 2d). This result sug-
gests that ROS is important for the up-regulation of HIF-1.
If hypoxia induced HIF1-α expression is mainly depend-
ent on ROS, ROS should also be able to directly activate
HIF1-α expression without hypoxic condition. Indeed, we
showed that when ROS were increased by XO gene trans-
fection, which altered the cellular microenvironment in
SMMC-7721 cells, HIF1-α protein expression was up-reg-
ulated. The HIF1-α targeted glycolytic enzyme such as
HK2 and LDH were accordingly increased in XO-7721
cells. Antioxidant treatment could abolish the increase
Enhanced endogenous ROS up-regulate glycolytic activityFigure 3 (see pr vi page)
Enhanced endogenous ROS up-regulate glycolytic activity. (a) Quantification of ROS levels in SMMC-7721 cells in 
comparison with their XO-transfected cells. SMMC-7721 cells were transfected with a void vector (XO-) or a vector express-
ing XO (XO+) as described in "Materials and methods". In some cases XO+ cells were treated with 5 mM α-LA for 24 h. ROS 
levels were measured by DCF fluorescence using flow cytometry as described in "Materials and methods". Data were 
expressed relative to control SMMC-7721 cells (XO-). (b) Enhanced XO expression caused an elevated protein level of HIF1-
α and HK2. In some cases XO+7721 cells were treated with 5 mM α-LA for 24 h. XO, HIF1-α and HK2 protein levels were 
assessed by Western blot as described in "Materials and methods". The present blots are representative of three experiments. 
(c) Comparison of glycolytic enzymes activity (LDH activity) in SMMC-7721(XO-) and XO-transfected 7721 cells (XO+). LDH 
activity levels are expressed relative to control SMMC-7721 cells (XO-). * P < 0.05 versus 7721 cells (XO-) in the absence of 
α-LA treatment (a, c); **, P < 0.05 versus XO+7721 cells in the absence of α-LA treatment (a). Columns: means ± S.D. of four 
independent experiments.Page 8 of 15
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sized and degraded under non-hypoxic conditions due to
rapid hydroxylation by proly 4-hydroxylase (PHD).
Therefore normally the level of HIF1-α is very low. Recent
studies show that various oxygen species can promote
HIF-1α stabilization by inhibiting PHD [34,35]. HIF-1
was shown to be able to regulate glycolysis and respiration
through mediating expression of pyruvate dehydrogenase
kinase [36]. Therefore, the excessive ROS may, through
inhibiting PHD, promote HIF-1α stabilization, causing
the high level of HIF1-α, which results in the up-regula-
tion of glycolysis.
Increasing endogenous ROS by gene transfection can
cause increased glycolytic activity (Fig. 3). This suggests a
critical role of the cellular oxidative stress in the Warburg
effect. Decreasing cellular ROS level either by antioxidant,
or by MnSOD transfection can decrease glycolytic activity
(Fig. 4). This further suggests the reliance of the Warburg
effect on ROS. This characteristic is consistent with our
previous finding that tumor cells growth is dependent on
ROS [7,13]. Therefore a cellular oxidative stress microen-
vironment is important for the tumor specific Warburg
effect in hepatoma cells, glycolysis could be activated in a
ROS dependent but hypoxia-independent manner. This
also could explain the mechanism whereby tumor cells
rely on aerobic glycolysis even in the present of oxygen so
displaying the Warburg effect.
Although growing evidences suggest that cancer cells are
under increased ROS and ROS-induced oxidative stress
compared to normal cells, conflicting results regarding
redox states in tumor cells have also been reported [37-
39]. Our results suggest that SMMC-7721 hepatoma cells
have a much higher level of oxidative stress than L02 nor-
mal liver cells. These results were validated by directly
detecting free radical signal in cellular microenvironment
using ESR spectrum method. In the present study, using
BMPO spin trap and SOD interference, free radical signals
in various hepatoma cell lines were captured and the main
source of free radicals was confirmed to be superoxide
anion free radical (Fig. 5a). However, no obvious free rad-
ical signal can be seen in normal L02 liver cells. HepG2
hepatoma cells were found to have similar higher level of
oxidative stress compared to Chang liver cells (data were
not shown here). We have also measured other type of
tumor cells such as gastric cancer cells, they presented the
same characteristic. Furthermore, the cellular oxidative
stress increased according to a decreasing degree of differ-
entiation in four gastric cancer cell line [40]. This suggests
that a higher oxidative stress level in malignant tumor
cells is not just a specific feature of a single cell line. The
conflicting results seen in other studies might be due to
experimental models or failure to assess cellular ROS
level.
Our results also suggest that the immortalized normal
liver cell lines behave similarly to normal cells rather than
cancerous cells. As shown in Fig. 5a, the L02 cells have rel-
atively lower intrinsic ROS levels, like normal liver cells.
Meanwhile they also have lower glycolytic activity (Fig.
1c, Fig. 5c), a property which is also shared by normal
liver cells. Our results also suggest that the Warburg effect
is related to a high level of cellular ROS and HIF-1 in
tumor cells, which is different to the phenomena seen in
the normal cell lines. Our results also show that antioxi-
dant α-LA can through inhibiting glycolytic activity inhib-
its hepatoma cell growth, and at a certain dose it can
Reduction of cellular ROS decreases glycolytic activityFig re 4
Reduction of cellular ROS decreases glycolytic activ-
ity. (a) Cellular ROS was decreased either by ROS scaveng-
ing or by MnSOD transfection. (b) LDH activity was inhibited 
by reduction of cellular ROS. SMMC-7721 cells transfected 
with a void vector (SOD-) or with a vector expressing SOD 
(SOD+) were incubated for 24 h in the presence or absence 
of 5 mM α-LA. ROS levels (a) were determined by DCF fluo-
rescence, and LDH activity levels (b) were measured as 
described in "Materials and methods". Results were 
expressed relative to control SMMC-7721 cells (SOD-) in 
the absence of α-LA treatment. * P < 0.05 versus control 
SMMC-7721 cells (SOD-) in the absence of α-LA treatment. 
The values represent the means ± S.D. from three separated 
experiments.Page 9 of 15
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Cellular ROS levels and relative LDH activitiesFigure 5
Cellular ROS levels and relative LDH activities. (a) ROS production monitored by ESR spectroscopy. 3 × 106 cells/ml 
SMMC 7721 hepatoma cells (Panel a) or L02 liver cells (Panel b), or SOD-transfected 7721 cells (Panel c), or antisense-SOD-
transfected 7721 cells (Panel d) were incubated with BMPO (100 mM). ROS production was assessed by ESR spectroscopy as 
described under "Materials and methods". In panel (e) SMMC-7721 cells were treated as in panel (a) with SOD (100 U/mL). 
The present spectrums are representative of three experiments. (b) Comparison of cellular LDH activity. LDH activity levels in 
SMMC-7721 cells, L02 cells, SOD-transfected 7721 cells (SOD-7721) and antisense-SOD-transfected 7721 cells (SOD-
AS7721) were measured as described in "Materials and methods". LDH activity was expressed relative to control SMMC-7721 
cells. Columns: * P < 0.05 versus control SMMC-7721 cells. The values represent the means ± S.D. from four independent 
experiments.
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same treatment was not harmful to L02 liver cells. As ROS
can through HIF-1 increase glycolysis, a certain ROS level
will benefit cancer cell growth. Scavenging ROS can
induce apoptosis through inhibiting cancer cell growth.
However, the L02 normal cell line under normoxia condi-
tions has lower a ROS level and lower glycolytic activity.
Energy generation is mainly through oxidative phosphor-
ylation, and so these cells are relatively insensitive to ROS
scavengers.
In addition to its antioxidant properties α-LA is also
known to be a co-factor of many enzymes such as pyru-
vate dehydrogenase complex involved in the oxidative
phosphorylation. The effect of α-LA could in part be due
to its non-antioxidant function. Taking into consideration
that many tumor cells have dysfunctional mitochondria
resulting in dysfunctional oxidative phosphorylation and
upregulated glycolysis, α-LA may not benefit cancer cell
through increasing oxidative phosphorylation. Contra-
rily, LA may through scavenging ROS inhibit glycolysis
and inhibit the energy supply of cancer cells. We have
tested other antioxidants treatment such as NAC and Res-
veratrol and found similar (data were not shown here).
This suggests that the antioxidant function of α-LA may
play a primary role.
The xenograft tumor studies also have shown similar
results. Nude mice injected with SOD-7721 cells showed
a delay in tumor formation as compared with those
injected with SMMC-7721 cells. In recent years, human
tumor xenografts have been successfully inhibited
through decreasing HIF-1 level by using exogenous anti-
oxidants [15], and several antioxidant trials have been
conducted against cancer [41]. In these trials antioxidants
were applied as a supplemental treatment. However, the
overall effects in trials are not significant, in some cases
negative effects have also been reported [42]. These results
may be explained by different redox status in different
cells. As we demonstrate in this paper, effective inhibition
of tumor cell growth may be achieved by altering the cel-
lular oxidative stress. It is known that malignant cells of
different cancer types exhibit heterogeneity in levels of
oxidative stress, associated with various expression levels
of SOD and other antioxidant enzymes [37-39,43].
Patients usually also have various degrees of oxidative
stress in vivo according to their cancer stage [44]. There-
fore, it may be critical to effectively monitor cellular ROS
level and the associated energy supply pathway in the
microenvironment of tumor tissue and tumor cells during
administration of antioxidants to treat cancer.
Conclusion
Taken together, these results suggest that altering cellular
redox level in hepatoma cells can modulate the tumor
specific Warburg effect, and that the cellular oxidative
stress microenvironment is important for hepatoma cells
to rapid growth, which may be applicable for cancer in
general. The mechanism allowing hepatoma cells through
oxidative stress to ectopically activate glycolysis could be
exploited to selectively kill tumor cells through interfer-
ence with energy pathways.
Methods
Cell culture and hypoxia exposures
The human hepatoma cell line SMMC-7721 was obtained
from Shanghai Institute of Cell Biology. The human
hepatoma cell line HepG2, and human hepatocyte cell
lines L02 and Chang were generously provided by Insti-
tute of Zhongshan Hospital. Cells were maintained in
RPMI-1640 (Gibcol BRL) supplemented with 10% heat-
inactivated (56°C, 30 min) fetal bovine serum, L-
glutamine (2 mM), penicillin (100 units/mL), streptomy-
cin (100 μg/mL), at 37°C in a humidified environment of
5% CO2-95% air. After cells were serum starved for 24
hours, cell culture media was replaced by hypoxic
medium (obtained by bubbling the serum free RPMI
medium or serum free RPMI medium supplement with
Reduction of ROS inhibits the growth of tumor cells and xenograft tumorsFig re 6 (see previous page)
Reduction of ROS inhibits the growth of tumor cells and xenograft tumors. (a) Reduction of ROS inhibits SMMC-
7721 hepatoma cells growth. SMMC-7721 hepatoma cells were administrated with 5 mM α-LA or transfected with MnSOD 
gene (SOD-7721 cells) to downregulate cellular ROS. Cells were harvested at day 1, 2, 3 and 4. Cell growth was monitored by 
live cell counting using trypan blue exclusion method. (b) Comparison of different doses of α-LA on the growth of SMMC-7721 
hepatoma cells and L02 immortalized normal liver cells. Cells were treated with 1, 2.5, and 5 mM α-LA, and harvested at 3 days 
after treatment. Cell growth was monitored by live cell counting using trypan blue exclusion method. (c) α-LA induces apopto-
sis in SMMC-7721 human hepatoma cells. Cells were cultured for 3 days with 1 mM, 2.5 mM and 5 mM α-LA. Apoptosis was 
evaluated by TUNEL as described in methods. (d) Tumor sizes in nude mice bearing human tumor xenografts. Nude mice were 
injected with SMMC-7721 cells transfected with a void vector or a vector expressing SOD (SOD-7721) as described in the 
methods. Tumor sizes were measured in three directions every 5 days. (e) Tumor masses in nude mice bearing human tumor 
xenografts. After 5 weeks, mice were killed and tumor masses were weighted. For cell experiments, the values represent the 
means ± S.D. from three separated experiments. * p < 0.05 compared with SMMC-7721 cells. For animal experiments, results 
were expressed as means ± S.D., n = 10 per group. * p < 0.05, compared with mice bearing SMMC-7721 cells.Page 12 of 15
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2% O2:93% N2:5% CO2, or 5%O2:90% N2:5% CO2 gas
mixture). The flasks were then gassed with appropriate
hypoxic gas mixture and incubated for indicated time at
37°C in a closed system.
Plasmids and transfection
For overexpression of MnSOD to downregulate ROS lev-
els, or inhibtion of MnSOD to increase ROS level, plas-
mids containing sense or antisense cDNA of human
MnSOD were used. pHβ A-SOD(+) or pHβ A-SOD(-)
plasmids (kindly provided by Professor Kunitaka Hirose)
were transfected into SMMC-7721 cells and establish
human SMMC-7721 hepatoma cell lines with stable
expression of MnSOD (represent as SOD-7721 cells) or
with suppressed expression of MnSOD (represent as SOD-
AS7721) using a standard method as described before [7].
For overexpression of XOR to enhance ROS levels, a retro-
viral construct encoding human xanthine oxidase (XO)
cDNA (hXO) was used to produce SMMC-7721 cells over-
expressing hXO [45]. A pLNCX2-XO construct (kindly
provided by Professor Pin XU) was infected into SMMC-
7721 cells, and established a human SMMC-7721
hepatoma cell line with stable expression of XO (repre-
sent XO-7721 cells) [45].
Assessment of cell growth, cell survival rate and apoptosis
Cells were trypsinized with 0.25% trypsin and harvested
at different time point. Cell number was counted using a
haemocytometer by adding 0.2% trypan blue which
stains the cytoplasm of dead cells but not live cells. Live
cells were counted using this trypan blue exclusion
method. Cell survival rate were calculated according to
following formula: Cell survival rate(%) = number of sur-
vival cells/number of total cells (*100%). SMMC-7721
cell apoptosis was assessed by terminal deoxynucleotidyl
transferase (Tdt) mediated dUTP Nick End Labelling
(TUNEL) analysis using flow cytometry as descibed before
[46].
Nuclear extracts and Western blotting analysis
Nuclear and cytosolic fractions were isolated using NE-
PER Nuclear and Cytoplasmic Extraction Reagents accord-
ing to the instructions of the manufacturer (Pierce, Rock-
ford, IL). Whole-cell lysates were prepared and Western
blotting was performed as previous described [46]. Anti-
HIF-1α monoclonal Antibody (BD Transduction Labs),
anti-XO antibody (NeoMArkers), anti-hexokinase 2 anti-
body and anti-horseradish peroxidise (HRP)-conjugated
antibody (Santa Cruz Biotechnology) were used for
immunoblot assays.
Measurement of reactive oxygen species
Intracellular ROS was assessed using oxidation sensitive
probe 2',7'-dichlorodihydrofluorescein diacetate (DCFH)
(San Diego, CA) as described [46] and using electron spin
resonance (ESR) spectroscopy. In the DCFH method, the
oxidation insensitive 2, 7-dichlorofluorescein diacetate
(DCF) was used as a control to ensure that changes in
uptake, ester cleavage, and efflux of the probe had not
occurred. DCF fluorescence was determined by using 0.5
× 106 cells with a FACSCalibur (excitation wavelength,
488 nm; emission wavelength, 515–545 nm; Becton
Dickinson). For each sample 10000 events were collected.
Spin trapping agent combined with ESR spectroscopy can
directly assess cellular ROS. 10 μl spin trap 5-tert-butoxy-
carbonyl 5-methyl-1-pyrroline N-oxide (BMPO, 100 mM,
synthesized in our group) was added to a 90 μl cell sus-
pension (3 × 106 cells/ml in PBS, pH 7.4), and transferred
to a flat quartz ESR aqueous cell. ESR measurements were
carried out at room temperature using a Bruker-IBM ER
200D-SRC spectrometer equipped with an X-band (Ger-
many). Studies were performed using the experimental
conditions as previously described [13]. SOD (100 U/ml)
was added to cell suspension as indicated and analyzed as
described above.
Measurement of glycolytic activity
The cellular glycolytic activity was determined by measur-
ing the activity of key enzyme lactate dehydrogenase, and
glucose uptake and lactate production. Lactate dehydroge-
nase catalyzes the reaction: L-lactate + NAD+ in equilib-
rium pyruvate + NADH. The activity of lactate
dehydrogenase (LDH) was monitored spectrophotomet-
rically by measuring the increase in NADH at 340 nm pro-
duced in the lactate-to-pyruvate reaction [47]. Lactate
concentration in the culture medium was measured using
commercial chromatometric kits from Sigma. For cellular
glucose uptake, cells were incubated with glucose-free
RPMI-1640 with 1 μCi 2-deoxy-[3H]-D-glucose for 60
minutes. Then cells were washed three times with ice-cold
PBS. The radioactivity in the cells pallets was quantified by
liquid scintillation counting.
Tumor formation in nude mice
Subconfluent cells were detached and resuspended in the
media at a density at 2 × 107/ml. Male nude mice between
four to six weeks old (BALB/c, nu/nu, from Experimental
Animal Center of Shanghai, China Academy of Sciences),
weighting 18–20 g, were injected subcutaneously with 0.2
ml of SMMC7721 cells or SOD-7721 cells respectively at
two different sites. The tumor formation was assessed
every 5 days. The sizes of the subcutaneous tumor were
measured in three directions every 5 days. Five weeks after
injection, mice were killed by cervical dislocation, the
tumors were dissected and weighed.Page 13 of 15
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Data are given as mean ± S.D. of three to five individual
experiments. Comparisons between means were done by
using Student's t test for paired data using Microsoft EXCEL
software.
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